BioXcel Therapeutics Inc. (NASDAQ: BTAI) announced completion of the database lock for its SERENITY At-Home pivotal Phase 3 safety trial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE